PolicyFinancial Express
OPPI warns frequent drug price cuts may deter pharma investments
Negative-67
GreyOak summary
OPPI cautions that frequent government price cuts of 25-50% under Para 19 of DPCO 2013 could disrupt business plans and discourage investments. The association urges selective use of the provision and suggests strengthening reimbursement frameworks instead of relying solely on price reductions.
What it affects
- HealthcareNegative -67
Frequent price cuts may deter pharma investments.Rolling sentiment Positive +29